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Abstract
Liver fibrosis occurs as a consequence of chronic injuries from viral infections, metabolic 
disorders, and alcohol abuse. Fibrotic liver microenvironment (LME) is characterized by excessive 
deposition and aberrant turnover of extracellular matrix proteins, which leads to increased tissue 
stiffness. Liver stiffness acts as a vital cue in the regulation of hepatic responses in both healthy 
and diseased states; however, the effect of varying stiffness on liver cells is not well understood. 
There is a critical need to engineer in vitro models that mimic the liver stiffness corresponding to 
various stages of disease progression in order to elucidate the role of individual cellular responses. 
Here we employed polydimethyl siloxane (PDMS) based substrates with tunable mechanical 
properties to investigate the effect of substrate stiffness on the behavior of primary rat hepatocytes. 
To recreate physiologically relevant stiffness, we designed soft substrates (2 kPa) to represent the 
healthy liver and stiff substrates (55 kPa) to represent the diseased liver. Tissue culture plate 
surface (TCPS) served as the control substrate. We observed that hepatocytes cultured on soft 
substrates displayed a more differentiated and functional phenotype for a longer duration as 
compared to stiff substrates and TCPS. We demonstrated that hepatocytes on soft substrates 
exhibited higher urea and albumin synthesis. Cytochrome P450 (CYP) activity, another critical 
marker of hepatocytes, displayed a strong dependence on substrate stiffness, wherein hepatocytes 
on soft substrates retained 2.7 fold higher CYP activity on day 7 in culture, as compared to TCPS. 
We further observed that an increase in stiffness induced downregulation of key drug transporter 
genes (NTCP, UGT1A1, and GSTM-2). In addition, we observed that the epithelial cell phenotype 
was better maintained on soft substrates as indicated by higher expression of hepatocyte nuclear 
factor 4α, cytokeratin 18, and connexin 32. These results indicate that the substrate stiffness plays 
a significant role in modulating hepatocyte behavior. Our PDMS based liver model can be utilized 
to investigate the signaling pathways mediating the hepatocyte-LME communication to understand 
the progression of liver diseases.
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Introduction
Noninvasive elastography techniques and direct rheometry measurements of the whole liver 
have established that the liver stiffness increases as fibrosis progresses.1–4 Studies of both 
humans and rats suggest that increased liver stiffness is associated with progression of 
fibrosis.5–7 Rat models subjected to carbon tetrachloride treatment demonstrate that the 
stiffness preceded fibrosis and similarly, an increase in liver stiffness was observed before 
the onset of fibrosis in patients with chronic hepatitis C infection.3 Despite these data, there 
is a lack in the complete understanding of the role of mechanical cues elicited by varying 
stiffness on different hepatic cells. The effects of changes in liver stiffness on overall hepatic 
functions and the liver stiffness threshold beyond which fibrosis is effectively irreversible is 
also poorly understood. Hence, it is prudent to reexamine the assumptions about the 
mechanism of fibrosis development and investigate the role of liver microenvironment factor 
such as varying stiffness on the liver cells. Thus far, in vivo models have been used to study 
liver fibrosis with the limitation of being inherently complex to delineate mechanistic 
pathways. Numerous in vitro human liver models have been developed during the last two 
decades to supplement animal models; however, these models primarily investigate co-
cultures and the effect of other vital aspects of liver microenvironment including change is 
stiffness is largely unexplored.8–16
The liver is a complex multicellular organ that performs numerous vital metabolic, synthetic 
and clearance-related functions in the body and the parenchyma of the liver consists of 
hepatocytes.17 Culture of these epithelial cells can exhibit many hepatic functions for a finite 
period. Studying the loss of hepatic functions such as urea and albumin synthesis, 
supplementing study of the non-specific end points, can be utilized as the tool to evaluate the 
effect of an external stimulus on the cellular behavior. Studies investigating the role of 
matrix stiffness on hepatocyte biology have observed that hepatocytes remain differentiated 
(functional) on soft supports and dedifferentiate (lose their functions) on stiff supports.18–20 
Studies have also demonstrated that when cultured on stiff, thin films of monomeric 
collagen, hepatocytes spread, proliferate, and otherwise adopt a dedifferentiated phenotype, 
whereas on soft gels of fibrillar collagen or matrigel, they remain differentiated and growth 
arrested.21,22 The primary goal of these studies was to extend the differentiated function of 
hepatocytes in order to use these as platforms for drug screening and toxicity studies and the 
effect of stiffness was not investigated in detail. Furthermore, it is inherently difficult to 
utilize bio-responsive materials such as collagen to the study the isolated effect of 
mechanical cues, independent of the ligand density. Recent studies have explored the use of 
synthetic substrates of varying mechanical properties to examine hepatic phenotype 
expression. Chen and co-workers demonstrated that primary hepatocytes cultured on varying 
elastic modulus of polyelectrolyte multilayers had decreasing albumin production with 
increasing film stiffness.12 Semler and co-workers investigated the effects of graded 
mechanical compliance on the function of primary hepatocytes using modified 
polyacrylamide gels with cell adhesive ligands and demonstrated that increasing hydrogel 
compliance resulted in increased albumin secretion.23 You and co-workers utilized heparin 
based hydrogels to investigate the effect of varying stiffness on primary hepatocytes 
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function.24 However, a comprehensive understanding of the effect of different stiffness 
ranges that correspond to various stages of liver fibrosis is lacking.
In our study, we utilized a polydimethyl siloxane (PDMS) based substrate with tunable 
mechanical properties to study the effect of varying stiffness on the phenotype of primary rat 
hepatocytes. PDMS is a silicon-based organic polymer commonly used to engineer 
constructs with a wide range of micro- and nano-topographies. PDMS has also been used 
extensively as a biomaterial to study cell–substrate interactions because of its 
biocompatibility,25–28 low toxicity,28–30 and high oxidative and thermal stability.31,32 PDMS 
is elastic, optically transparent, has low permeability to water, and low electrical 
conductivity.33,34 These properties have made this material attractive for use in cell biology 
studies, including contact guidance, chemotaxis, and mechanotaxis.35–39 Our working 
hypothesis is that variation in matrix stiffness will influence hepatocyte phenotype and 
function, and that hepatocytes will subsequently develop fibrosis-like responses to 
mechanical perturbation. We employed a soft substrate (2 kPa) to represent the healthy liver 
tissue stiffness and stiff substrate (55 kPa) to represent the diseased liver tissue and 
compared the cellular properties with the cells grown on TCPS.40–42 We studied the effect 
on primary hepatocytes including cell adherence, morphology, hepatic-specific functions 
including urea and albumin production, cytochrome activity and functional gene expression 
levels. We also probed for the expression levels of epithelial markers, in order to evaluate the 
maintenance of differentiated phenotype of the cells. Our observations demonstrate a strong 
dependence of primary hepatocyte function and phenotype on the culture substrate stiffness 
thus indicating the crucial role the mechanical environment plays in the maintenance of the 
normal function and in the progression of liver diseases.
Materials and methods
Preparation of PDMS substrates
Sylgard 527 and Sylgard 184 (Fisher Scientific, USA) were blended in various weight ratios 
for creating PDMS substrates with the desired stiffness for culturing primary hepatocytes. 
As per manufacturer’s guidelines, Sylgard 527 was taken in equal weights of part A and part 
B to enable cross-linking and mixed well to maintain homogeneity. Sylgard 184 was taken in 
10 : 1 ratio of the elastomer to crosslinking agent and mixed well. The two Sylgard 
precursors were then mixed in varying weight ratios and poured into 12 well tissue culture 
plates. The plates were incubated at 65 °C overnight to ensure complete crosslinking of the 
mixture, to yield uniform PDMS substrates.
Young’s modulus measurements
Measurement of Young’s modulus was carried out using TMS-Pro texture analyzer (Food 
Technology Corporation, Sterling, VA). The height and diameter of the PDMS discs were 
measured using a caliper. The samples were compressed and, the force and the 
corresponding displacement were recorded and used to construct stress–strain curves. 
Young’s modulus values were determined from the linear regions of the stress–strain curve.
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Collagen coating of the culture substrates
After overnight crosslinking, the plates containing PDMS substrates were subjected to 
oxygen plasma treatment for 7 minutes under the medium RF settings (Plasma Cleaner 
PDC-001, Harrick Plasma, Ithaca, NY). The plates were coated with 0.1 mg ml−1 type 1 
collagen solution maintained in 0.02 N acetic acid obtained from rat tail. After overnight 
incubation at 4 °C, the plates were washed with Phosphate Buffer Saline (PBS) and 
sterilized under UV.
Isolation and culture of primary hepatocytes
All the animal procedures were performed in accordance with the recommendations and 
guidelines from IACUC at University of Nebraska-Lincoln. Primary rat hepatocytes were 
isolated from male Sprague-Dawley rats (160–200 g weight) following a two-step 
collagenase perfusion protocol adapted from P.O Seglen.43 Around 150–200 million cells 
were obtained at a viability greater than 90% as confirmed through Trypan blue dye 
exclusion test. Cells were seeded at a density of 100 000 cm−2 on the collagen coated PDMS 
substrates and TCPS. Cells were maintained in a humidified 5% CO2 incubator at 37 °C and 
cell culture media was replaced every 24 hours.
Primary hepatocyte culture medium
Hepatocyte culture medium was prepared with high glucose DMEM supplemented with 
10% FBS, 0.5 U ml−1 insulin, 20 ng ml−1 epidermal growth factor (EGF), 7 ngml−1 
glucagon, 7.5 mg ml−1 hydrocortisone, and 1% penicillin–streptomycin. All the reagents 
were obtained from Sigma Aldrich, USA.
Cell morphology, adhesion and cell area analysis
Phase contrast images of primary hepatocytes cultured on the different substrates were 
captured using an Inverted Microscope (Axiovert 40 CFL, Zeiss, Germany). For the cell 
attachment, cell area calculation, hepatocytes were seeded at a subcon fluent density of 50 
000 cells per cm2. To quantify the adhesion of cells, 10 images of each substrate type were 
captured and the total number of cells attached per unit area was calculated by counting the 
number of cells using the built-in cell counter feature in Image J. Image J software was also 
used to calculate the individual cell area using a total of 150 cells per sample.
Cell viability assay
The viability of primary hepatocytes on the different substrates was quantified using MTT 
assay (3-(4,5-dimethylthiazol-2-yl)2,5 diphenyltetrazolium bromide) (Life Technologies, 
NY). This assay evaluates the mitochondrial conversion of the MTT salt by viable cells to 
insoluble formazan crystals. Briefly, the cell media was aspirated, and 0.5 mg ml−1 MTT 
working solution in DMEM was incubated on live cells at 37 °C for 2.5 hours. After 
incubation, the working solution was removed, and lysis buffer (0.1 N HCl in isopropanol) 
added to dissolve the purple formazan crystals. Formazan containing lysis buffer was 
transferred to a 96 well plate and absorbance values collected in an AD340 plate reader 
[Beckman Coulter, city, state] at corrected 570/620 nm. Relative absorbance was used as the 
indicator of cell viability.
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Urea quantification
Urea secretion in hepatocyte culture medium was quantified using Stanbio Urea Nitrogen 
(BUN) kit (Stanbio, Boerne, TX) using manufacturer’s instructions. The kit utilizes the 
reaction between urea secreted in the culture medium and diacetyl monoxime which results 
in a color change that can be quantified at an absorbance of 520 nm read on AD 340 plate 
spectrophotometer (Beckman Coulter, Brea, CA).
Albumin quantification
Albumin secretion in hepatocyte culture medium was quantified using the rat albumin 
sandwich ELISA quantitation kit from Bethyl Laboratories, Inc. (Montgomery, TX) 
according to manufacturer’s instructions. In short, a 96 well plate was coated with a coating 
antibody for 1 hour and blocked with bovine serum albumin (BSA) for 30 minutes. 
Standard/sample was added to each well and incubated for 1 hour. Horse Radish Peroxidase 
(HRP) tagged detection antibody was incubated for 1 hour followed by the addition of 
tetramethylbenzidine (TMB) substrate solution which was developed in the dark for 15 
minutes and absorbance read on AD340 plate spectrophotometer (Beckman Coulter, Brea, 
CA) at 450 nm. Intra- and inter-assay variability were less than 10% for all the albumin 
ELISA. The limit of detection was 1.95 ng ml−1.
Cytochrome P450 activity assay
Cytochrome P450 activity in primary hepatocytes was induced using 3-methylcholanthrene 
(3-MC) at a concentration of 2 μM. The culture media containing 3-MC was replaced every 
alternate day. Before the assay, cells were incubated in 80 μM dicumarol prepared in PBS 
for 20 minutes. Ethoxy resorufin o-dealkylase (EROD) activity was measured by incubating 
cells with phenol red and serum free media containing 5 μM ethoxyresorufin. Cell 
supernatant was collected at various time points (0, 20, 30, 40 and 50 minutes). The 
supernatant was read at an emission of 590 nm and excitation of 530 nm using SLFA plate 
reader (Biotek, Winooski, VT). Cytochrome activity was calculated as pmol min−1 and 
plotted after normalization with respect to the corresponding TCPS samples.
Gene expression analysis
At each time point, total RNA from primary hepatocytes was isolated using Trizol (Life 
Technologies, NY) following the manufacturer’s instructions. Briefly, cells were trypsinized, 
centrifuge pelleted, washed with PBS and lysed in Trizol. Chloroform was added to the cell 
lysates, and RNA was separated out in the aqueous phase. RNA was precipitated using 
isopropyl alcohol and rinsed with 75% ethanol twice to remove impurities. Finally, the RNA 
pellet was reconstituted in RNase free water. The quality and quantity was determined by 
ND-1000 spectrophotometer (NanoDrop Technologies Wilmington, DE) and reverse 
transcribed using iScript™ cDNA synthesis kit (Bio-Rad Laboratories, CA) by following 
manufacturer’s instructions.
Quantitative real-time PCR was performed using SYBR Green Master Mix (Applied 
Biosystems, Foster City, CA) in an epgradient S Mastercycler (Eppendorf, NY). The primers 
of interest obtained from Integrated DNA Technologies (Coralville, IA) as listed in Table 1. 
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GAPDH was used as the housekeeping gene and the ΔΔCT method was utilized for the 
analysis of the relative expression levels of the target genes.
Statistical analysis
Data were expressed as the mean ± SD from three independent experiments. The difference 
between the various experimental groups was analyzed by a one-way analysis of variance 
(ANOVA) using the statistical analysis feature embedded in SigmaPlot Software using 
Tukey test. Q tests were employed to identify outliers in the data subsets. For statistical 
analysis of all data, p < 0.05 was used as the threshold for significance. Threshold of 10% 
CV was used for intra- and inter-assay variability in ELISAs.
Results
We cultured primary rat hepatocytes on collagen coated PDMS substrates of stiffness that 
corresponds to the healthy (2 kPa) and the diseased liver (55 kPa)42 and investigated the role 
of matrix stiffness in regulating the cellular phenotype and key hepatocyte functions.
Characterization of the elastic modulus of the PDMS substrates
Palchesko and co-workers demonstrated that the PDMS formulations based on the blending 
of commercially available Sylgard 527 and Sylgard 184 can be used to create biomaterials 
with tunable elastic modulus over three orders-of-magnitude.44 We used similar strategy in 
our study and mixed varying weight percentages of Sylgard 184 with Sylgard 527 to obtain 
substrates with different stiffness. We measured elastic modulus (quantification of surface 
stiffness) of the soft (100% Sylgard 527) and stiff (85% by weight Sylgard 527 and 15% by 
weight Sylgard 184) substrates developed using indentation load technique as 2.36 ± 0.04 
kPa and 54.98 ± 2.1 kPa, respectively (Table 2) compared to 3 × 106 kPa in TCPS.45 These 
elastic moduli fall in the physiological liver stiffness range of healthy and diseased liver 
making them an ideal substrate to investigate the role of liver stiffness on hepatic function.42
Primary hepatocyte morphology and viability on PDMS substrates
We investigated the effect of substrate stiffness on morphology and viability of primary 
hepatocytes cultured on PDMS substrates coated with collagen and compared the results 
with TCPS coated with collagen (Fig. 1). We observed that on day 1 primary hepatocytes 
displayed similar morphology on soft, stiff and TCPS substrates (Fig. 1A). The cells 
demonstrated tight cell–cell junctions, visible cell boundaries and also displayed typical 
polygonal shape, all of which are indicative of the typical hepatocyte epithelial morphology. 
On day 5, the hepatocytes on TCPS displayed considerable increase in cell-spreading and a 
fibroblast-like morphology. Similar trend was observed, but to a lesser magnitude, in cells 
cultured on the stiff substrate. On the contrary, cells on the soft substrate retained the initial 
polygonal shape and visible tight junctions between the cells. Following changes in 
morphology, we studied cell viability using MTT assay (Fig. 1B). We observed that the cells 
grown on soft substrates had a higher viability as compared to hepatocytes on stiff and TCPS 
substrates indicating a potential effect of stiffness on hepatocytes.
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Primary hepatocyte cell attachment and cell spreading area
We investigated the effect of substrate stiffness on individual primary hepatocytes when 
seeded at a sub-confluent density of 50 000 cells per cm2. As seen in Fig. 2, the individual 
cell morphology displays a significant difference between soft, stiff and TCPS substrates. 
The individual cells on the soft substrate have significantly lower cell spreading area (66.1 ± 
18.7%) compared to the cells attached on stiff (88.7 ± 28.9%) and TCPS control (100 ± 
27.7%). We further measured the cell attachment on these substrates and the total number of 
cells attached per unit area was highest in soft substrates (768.1 ± 50.1 cells per mm2) 
compared to stiff (707.8 ± 33.9 cells per mm2) and TCPS control (577.4 ± 56.8 cells per 
mm2).
Effect of stiffness on urea production
We investigated the effect of substrate stiffness on urea production, a key functional marker 
for primary hepatocytes and an indicator of intact nitrogen metabolism and detoxification, 
over a duration of 7 days (Fig. 3A).20 Hepatocytes cultured on soft substrates produced 
155.4 ± 20.0 μg per ml per million cells urea on day 7 compared to 132.4 ± 28.2 μg per ml 
per million cells urea and 74.5 ± 19.3 μg per ml per million cells urea by hepatocytes 
cultured on stiff and TCPS substrates on day 7, respectively. Interestingly, primary 
hepatocytes cultured on stiff substrates recreating the diseased liver microenvironment 
produced significantly more urea as compared to those on TCPS, which is considered the 
gold standard culture substrate.
Effect of substrate stiffness on albumin
Albumin synthesis is a widely accepted marker of hepatocyte synthetic function.19,20 The 
long term metabolic response of continuous hepatocyte culture on soft and stiff substrates 
was compared with collagen coated surfaces by measuring albumin production as shown in 
Fig. 3B and C. Fig. 3B and C illustrate the rate of albumin production and albumin gene 
expression, respectively, for cultures up to one week. The daily production of albumin on 
soft and stiff surfaces were comparable and significantly higher than collagen coated TCPS 
surfaces. By day 7, the liver specific albumin production was approximately 8.9 μg per ml 
per million cells albumin in both soft and stiff compared to 1 μg per ml per million cells 
albumin on TCPS surface. We measured the albumin gene expression of hepatocytes 
cultured on these substrates on day 7 and observed that the soft and stiff substrates showed a 
4 fold and 2.5 fold higher albumin gene expression, respectively, compared to TCPS. The 
hepatocytes in the soft surfaces mimicking healthy liver environment had a significantly 
higher albumin gene expression when compared to stiff surfaces mimicking the diseased 
liver environment.
Effect of stiffness on cytochrome P450 activity
Cytochrome P450 enzymatic activity is a critical function of hepatocytes that plays an 
important role in the metabolism of multiple toxins, xenobiotics and pharmaceuticals.17 
Cytochrome P450 1A1/2 (CYP1A1/2) activity was monitored in hepatocytes cultured on 
soft, stiff, and TCPS control on days 3, 5, and 7 (Fig. 4A). Our goal was to investigate the 
effect of stiffness on the enzymatic kinetics over the observation period, since decrease in 
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enzymatic activity is usually indicative of a deteriorating phenotype. Thus, we report the 
difference in CYP enzyme activity on soft and stiff substrates as a fold change compared to 
TCPS on days 3, 5, and 7. CYP1A1/2 activity on soft substrates on days 3, 5, 7 was 4.5, 5.6, 
and 10.8 fold higher than TCPS. CYP1A1/2 activity on stiff substrates on day 3, 5, 7 was 
4.5, 4.4, and 8.2 fold higher than TCPS. Furthermore, the CYP activity of hepatocytes on 
soft substrates on day 7 was significantly higher than the cells on stiff substrates.
We also probed the gene expression levels of CYP1A1, CYP3A2 (rat species equivalent to 
the human CYP3A4 46), CYP3A18, and CYP1A2 (Fig. 4B). We observed that hepatocytes 
cultured on soft substrates demonstrated 2.7, 1.9, and 2.1-fold up regulation of CYP1A1, 
CYP3A2 and CYP3A18 gene expression, respectively, compared to TCPS. Cells cultured on 
stiff substrates had 1.2-fold increase in CYP1A1 gene expression and no significant change 
in CYP3A2 and CYP3A18 gene expression compared to TCPS. This indicates that the 
hepatocytes on soft substrates representative of healthy liver environment have better 
maintenance of drug metabolizing enzymes compared to disease like stiff substrates. 
Interestingly, CYP1A2 gene expression did not demonstrate up regulation on the soft 
substrate but showed 1.5 fold up regulation in the stiff substrate, compared to TCPS.
Effect of stiffness on the maintenance of hepatocyte specific markers
We evaluated the effect of stiffness on the differentiated epithelial-like phenotype of the 
hepatocytes cultured on the soft, stiff and TCPS substrates by probing the gene expression of 
hepatocyte nuclear factor 4α (HNF4α), cytokeratin 18 (CK18) and connexin 32 (Fig. 5A). 
We observed that hepatocytes cultured on the soft substrates demonstrated the highest 
degree of epithelial-like phenotype. Hepatocytes on soft and stiff surfaces had a 4-fold and 
2-fold higher HNF4α gene expression, respectively, compared to TCPS. Hepatocytes 
cultured on soft substrates had 1.6-fold higher CK18 gene expression compared to TCPS 
while cells on stiff substrates had comparable CK18 gene expression to TCPS. We also 
observed that hepatocytes cultured on soft substrates had 4-fold higher gene expression of 
connexin 32 compared to TCPS while cells cultured on stiff substrates had no significant 
change in connexin 32 gene expression compared to TCPS.
We also evaluated the role of matrix stiffness on primary hepatocyte functional gene 
markers-NTCP (sodium dependent bile acid transporter), GSTM-2 (glutathione S-
transferase mu 2) and UGT1A1 (UDP glycosyltransferase) (Fig. 5B). We observed that 
hepatocytes cultured on soft substrates resulted in 12-fold, 6-fold, and 25-fold upregulation 
of UGT1A1, GSTM-2, and NTCP gene expression, respectively, compared to TCPS. Cells 
cultured on stiff substrates had no significant change in GSTM-2 and NTCP gene expression 
compared to TCPS.
Discussion
Liver damage as a consequence of liver injury or disease (e.g., chronic hepatitis C virus 
[HCV] infection, alcohol abuse, and nonalcoholic steatohepatitis [NASH]) is extremely 
prevalent and results in a substantial economic burden on patients.47,48 Several liver diseases 
can lead to fibrosis, which results from an imbalance between production and resorption of 
extracellular matrix (ECM) and a restructuring of the liver microenvironment (LME). The 
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earliest changes in LME as a result of liver disease occur in response to ECM remodeling, 
resulting in accumulation of ECM proteins and an increase in liver stiffness. Furthermore, 
the distorted balance between matrix production and degradation leads to deleterious effects 
on the liver function. Clinical studies suggest that the altered LME provides a permissive 
milieu for the development of cellular dysplasia and is a key feature of liver dysfunction that 
leads to cirrhosis and hepatocellular carcinoma (HCC).49–51 There is a range of underlying 
mechanisms that contribute to liver diseases; however, despite extensive research over many 
decades, the precise molecular mechanisms of how the changes in liver stiffness affects liver 
function remain poorly understood. In this study, we utilized PDMS substrate with tunable 
elastic modulus for studying the stiffness-mediated effect on primary hepatocyte behavior. 
We identified two substrates with stiffness of 2 kPa (soft) and 55 kPa (stiff) as mimics for 
the LME of the healthy and the diseased liver.42
Recent reports have demonstrated the effect of stiffness on hepatocytes function.12,24 
However, the stiffness ranges employed in these studies have limitations with respect to 
recreating physiologically relevant conditions for healthy and diseased liver. In the platform 
used in this study, we adapted the method developed by Palchesko and co-workers by using 
different ratios Sylgard 527 and Sylgard 184 to tune the elastic modulus of PDMS.44 
Although not many cell culture studies have utilized Sylgard 527 as a substrate, we observed 
that the use of Sylgard 527 does not lead to any compromise in the cellular viability. PDMS 
mixtures of 527 and 184 also retain optical transparency that makes them an ideal substrate 
material for imaging cells. Although the material is inherently hydrophobic, studies have 
shown that oxygen plasma treatment temporarily modifies the surface Si–OH groups to 
render hydrophilicity.52 We utilized this surface modification to coat the substrates with 
collagen, which is commonly used for facilitating the adhesion of primary hepatocytes. The 
typical polygonal morphology of primary hepatocytes was retained in soft substrates and 
significantly lost on stiff and TCPS substrates after day 5 in culture. The cells also show 
some degree of aggregation in the TCPS substrates, which is a strong indication of de-
differentiation (loss of function) of hepatocytes. The polygonal shape and presence of visible 
boundaries between the cells are generally attributed to the differentiated state of the cells 
and the elongated fibroblast like morphology is associated with dedifferentiation and can 
also be associated with loss in membrane integrity.53 The viability of the cells was also 
significantly lowered in stiff and TCPS substrates when compared to soft substrates after day 
5 in culture demonstrating the potential compromise in hepatocytes viability in stiff 
(diseased liver mimic) surfaces. Together, these results indicate that the primary hepatocytes 
appear to be more differentiated on the soft substrate (healthy liver mimic), as compared to 
stiff and TCPS. Furthermore, the cells were more circular and had lesser spreading area in 
the soft substrate compared to stiff and TCPS surfaces. This observation is consistent with 
studies carried out by groups on other adherent cell types.54 The higher cell attachment of 
hepatocytes on soft compared to stiff substrates also demonstrates that hepatocytes when 
exposed to diseased liver like environment lose their viability akin to liver diseases.
A significant finding of our study was the higher production of urea and albumin on soft 
substrates compared to stiff substrates. Hepatocytes on both soft and stiff substrates 
displayed higher production of urea and albumin compared to TCPS, thus indicating that 
culturing hepatocytes on TCPS is a poor in vitro model to study hepatocyte function. These 
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trends clearly indicate that hepatocellular functions are also maintained, since urea and 
albumin are two of the key markers of hepatic function. In addition, we observed that the 
albumin gene expression was significantly higher in soft surfaces compared to both stiff and 
TCPS surfaces. Clinical studies have demonstrated that the expression of albumin mRNA in 
acute hepatic failure and decompensated liver cirrhosis was reduced significantly compared 
to normal control liver in human liver samples.55,56 These studies suggest that albumin 
concentration is mainly regulated at albumin mRNA level in the liver despite the presence of 
other regulatory mechanisms and that expression of albumin mRNA level is correlated with 
disease severity. We hypothesized that the hepatocytes on soft environment maintains the 
hepatic function longer compared to stiffer and TCPS surfaces as the soft substrates mimics 
the healthy LME while the stiff surfaces recreates the diseased LME. Our in vitro model 
recreates this phenomenon, thus increasing our confidence in our platform to mimic the 
clinical aspects of liver fibrosis. These data further indicate the need for tissue engineered 
liver models that recapitulate the mechanical environment found in vivo.55,56
Cytochrome P450 enzymatic activity in hepatocytes is critical for the liver to conduct 
detoxification of a wide range of toxins, drugs and xenobiotics. However, this function is 
lost in several liver diseases.57,58 Peterson and co-workers induced hepatic fibrosis in mice 
models and found that fibrotic livers had significant reduction in CYP1A subgroup levels.58 
Since liver stiffness increases with varying stages of liver disease, the understanding of how 
stiffness affects enzymatic activity is key for potential therapeutic strategies in the future. We 
focused our attention on a major class of CYP enzymes, CYP1A1/2, since this enzyme 
typically mediates the metabolism of drugs. The soft substrates exhibited higher enzymatic 
activity over seven-day observation period compared to stiff and TCPS surfaces. These 
trends were mirrored in the gene expressions of CYP1A1, CYP3A2 and CYP3A18. This 
indicates that substrate stiffness acts as an important cue in preserving the clearance 
functions of hepatocytes. These results are of prime interest when modeling hepatoxicity or 
drug screening studies in vitro. In a similar stiffness-mediated drug metabolism study, 
Zustiak and co-workers, demonstrated that various types of cells when cultured on different 
stiffness substrates showed varying drug resistance and thus, the substrate stiffness affects 
the reliability of the in vitro drug screening platforms.59 We also observed that hepatocytes 
on soft substrates have higher gene expression of key phase II transporters (NTCP, GSTM-2 
and UGT1A1).
Maintenance of epithelial phenotype and repression of dedifferentiation in hepatocytes is an 
important event in the progression of liver diseases.60 Homotypic hepatocyte interactions 
and gap junctions are marked by the expression of connexin 32.61 Connexin 32 is a vital gap 
junction protein expressed in hepatocytes that regulates the signal transduction related to cell 
function, growth and dedifferentiation in the liver.62 Clinical studies have reported 
significant decrease in the mRNA levels of connexin 32 in chronic liver diseases and 
cirrhosis.63 Cytokeratin 18 is an intermediate filament present in epithelial cells such as 
hepatocytes and the decrease in the cytokeratin 18 expression levels is indicative of 
dedifferentiating epithelial phenotype.60 Hepatic nuclear factor 4 alpha (HNF4α) plays an 
active role in the maintenance of the differentiated epithelial phenotype and in the repression 
of dedifferentiation in hepatocytes. 64 HNF4α is the regulator of multiple signaling cascades 
and hence directly mediates the expression levels of a broad spectrum of genes that are 
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involved in the maintenance of hepatocyte homeostasis.65 Clinical reports have 
demonstrated that cirrhosis and fibrotic liver have decreased levels of HNF4α expression, 
indicating the role they play in the altered hepatic functions such as lipid and carbohydrate 
metabolism, and bile acid synthesis in the diseased hepatocytes.66,67 Overall, these markers 
can be the vital mechanistic regulators of the maintenance of the phenotypic traits of 
hepatocytes. We observed that the soft substrate supports the highest level of differentiated 
hepatocyte maintenance as demonstrated by the expression of these key epithelial markers. 
Analogous to the maintenance of the differentiated phenotype in the soft substrate, we 
observed a more disease-like phenotype induction in the stiff substrate, entirely based on the 
mechano-signaling changes using the substrates. Therefore, together these data suggest that 
stiffness has a strong impact on hepatocytes function and substrates of varying stiffness 
might provide a method to recreate various stages of liver diseases.
In summary, we investigated the function of primary hepatocytes cultured on PDMS 
substrates that can be tuned to demonstrate varying stiffness. Our study demonstrates that 
stiffness of the culture substrate plays a crucial role in determining the phenotypic 
maintenance of primary hepatocytes. We observed that hepatocytes grown on the healthy 
liver stiffness (2 kPa) displayed a consistently more differentiated and functional phenotype 
for a longer duration as compared to the hepatocytes that were cultured on the stiff substrate, 
which represents the diseased liver (55 kPa) and, TCPS. Increase in liver stiffness is a strong 
indication of the progression of liver fibrosis. There is a critical need to engineer in vitro 
models that will mimic the various stages of liver disease to serve as accurate models for 
studying disease mechanism and drug and toxicity testing. Such models need to incorporate 
the dynamic changes in LME including the change in liver stiffness. In the current study, we 
demonstrate that hepatocytes phenotype and function is strongly modulated based on the 
stiffness the cells are exposed. Hepatocytes on environment comparable to healthy liver 
resulted in the simultaneous maintenance of their epithelial phenotype and increased 
hepatocellular functions compared to the cells on environment similar to the diseased liver. 
The intricate LME-hepatocytes signaling pathways through which these cells communicate 
within the LME will be further investigated in our future studies.
Supplementary Material
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Fig. 1. 
(A) Characterization of primary hepatocyte morphology when cultured on soft, stiff and 
TCPS substrates; (B) quantification of primary hepatocyte viability using MTT assay on day 
5 in culture, scale bar = 200 microns, significant difference between the soft/stiff group and 
TCPS group is denoted by ##p value < 0.005, significant difference between the soft and stiff 
group is denoted by *p value < 0.05.
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Fig. 2. 
(A) Phase contrast images primary hepatocytes on soft, stiff and TCPS substrates; (B) 
quantification of primary hepatocyte area normalized with respect to cells on TCPS; (C) 
quantification of total primary hepatocyte attachment per unit area after 24 hours in culture, 
scale bar = 100 microns, significant difference between the soft/stiff group and TCPS group 
is denoted by ##p value < 0.005, significant difference between the soft and stiff group is 
denoted by **p value < 0.005.
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Fig. 3. 
(A) Quantification of urea synthesis by primary hepatocytes on soft, stiff and TCPS 
substrates; (B) quantification of albumin synthesis primary hepatocytes cultured on soft, stiff 
and TCPS substrates using ELISA; and (C) gene expression analysis albumin of primary 
hepatocytes cultured on soft, stiff and TCPS substrates on day 7, significant difference 
between the soft/stiff group and TCPS group is denoted by #p value < 0.05, ##p value < 
0.005, significant difference between the soft and stiff group is denoted by *p value < 0.05.
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Fig. 4. 
(A) Quantification of cytochrome P450 activity of primary hepatocytes when cultured on 
soft, stiff and TCPS substrates; (B) gene expression analysis of cytochrome P450 gene 
markers of primary hepatocytes cultured on soft, stiff and TCPS substrates on day 7, 
significant difference between the soft/stiff group and TCPS group is denoted by #p value < 
0.05, ##p value < 0.005, significant difference between the soft and stiff group is denoted by 
**p value < 0.005.
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Fig. 5. 
(A) Gene expression analysis of epithelial cell markers of primary hepatocytes cultured on 
soft, stiff and TCPS substrates on day 7; (B) gene expression analysis of hepatic functional 
markers on day 7, significant difference between the soft/stiff group and TCPS group is 
denoted by #p value < 0.05, ##p value < 0.005, significant difference between the soft and 
stiff group is denoted by *p value < 0.05 and **p value < 0.005.
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